MIRUM PHARMACEUTICALS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/fe45f7a1-8efd-408b-8dc9-60b19215670b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $521.3M | 2025-01-01 – 2025-12-31 | evidence 0001759425-26-000013 |
| FY 2024 | $336.9M | 2024-01-01 – 2024-12-31 | evidence 0001759425-25-000014 |
| FY 2023 | $186.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-032289 |
| FY 2022 | $77.1M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-006715 |
| FY 2021 | $19.1M | 2021-01-01 – 2021-12-31 | evidence 0000950170-23-006715 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0000950170-22-003229 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
MIRUM PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income